haloperidol has been researched along with substance p in 74 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 35 (47.30) | 18.7374 |
| 1990's | 31 (41.89) | 18.2507 |
| 2000's | 5 (6.76) | 29.6817 |
| 2010's | 3 (4.05) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Costa, E; Hong, JS; Yang, HT | 1 |
| Costa, E; Gale, K; Guidotti, A; Hong, JS; Toffano, G | 1 |
| Leeman, SE; Pettibone, DJ; Wurtman, RJ | 1 |
| Evered, MD; Fitzsimons, JT | 1 |
| Costa, E; Hong, JS | 1 |
| Krause, JE; Sivam, SP | 1 |
| Auer, B; Haring, C; Humpel, C; Knaus, GA; Knaus, HG; Saria, A; Theodorsson, E | 1 |
| Elliott, PJ; Lorens, SA; Mitsushio, H; Paris, JM | 1 |
| Michael, RP; West, CH | 1 |
| Oblin, A; Zivkovic, B | 1 |
| Elliott, PJ; Hagan, RM; Mason, GS; Stephens-Smith, M | 1 |
| Bloom, SR; Ghatei, MA; Jones, PM; O'Halloran, DJ | 1 |
| Bartholini, G; Oblin, A; Zivkovic, B | 1 |
| Kamiya, H; Takano, Y; Takeda, Y; Yamada, K | 1 |
| Barrett, JE; Brady, LS | 1 |
| Affolter, HU; Bannon, MJ; Bonner, TI; Giraud, P; Lee, JM; Young, A | 1 |
| Brodin, E; Lindefors, N; Ungerstedt, U | 2 |
| Nylander, I; Terenius, L | 1 |
| Bouras, C; Constantinidis, J; Schulz, P; Tissot, R | 1 |
| Hong, JS; Huang, YS; Li, SJ; McGinty, JF; Sivam, SP | 1 |
| Fibiger, HC; MacLennan, AJ; Radke, JM; Vincent, SR | 1 |
| Mataga, N; Mitsushio, H; Takashima, M; Toru, M | 1 |
| Beckstead, RM; Cruz, CJ | 1 |
| Dourish, CT; Iversen, SD; Stoessl, AJ | 1 |
| Maigret, C; Van Wimersma Greidanus, TB | 1 |
| Hong, JS; Krause, JE; Li, S; McGinty, JF; Sivam, SP; Takeuchi, K | 1 |
| Burns, LH; Kelley, AE | 1 |
| Simasko, SM; Weiland, GA | 1 |
| Pettibone, DJ; Wurtman, RJ | 1 |
| Abe, H; Chihara, K; Imura, H; Iwasaki, Y; Kato, Y | 1 |
| Alphs, L; Hanson, G; Lovenberg, W; Pradhan, S | 1 |
| Barbeau, A; Belanger, F; Fouriezos, G; Jolicoeur, FB; Rondeau, DB | 1 |
| Alphs, L; Hanson, GR; Levine, R; Lovenberg, W; Wolf, W | 1 |
| Janicki, P; Libich, J; Lypko, A; Szczudlik, A | 1 |
| Hong, JS; Tilson, HA; Yoshikawa, K | 1 |
| Barbeau, A; Jolicoeur, FB; Rondeau, DB | 1 |
| Kato, T; Koshiya, K | 1 |
| Bartholini, G; Lloyd, KG; Scatton, B; Worms, P | 1 |
| Gibb, JW; Hanson, GR; Ritter, JK; Schmidt, CJ | 1 |
| Bannon, MJ; Goedert, M | 1 |
| Gale, K; Melis, MR | 1 |
| Alberch, J; Arenas, E; Marsal, J; Pérez-Navarro, E | 1 |
| Castel, MN; Dagerlind, A; Hökfelt, T; Morino, P | 1 |
| Bloch, B; Fournier, MC; Jaber, M; Tison, F | 1 |
| Jackson, A; Rupniak, NM | 1 |
| Cornish, JL; van den Buuse, M | 1 |
| Egan, MF; Hurd, Y; Hyde, TM; Kleinman, JE; Weinberger, DR; Wyatt, RJ | 1 |
| Phend, KD; Rustioni, A; Weinberg, RJ | 1 |
| Jenner, P; Jolkkonen, J; Marsden, CD | 1 |
| Aguilar, C; Mattioli, R; Vasconcelos, L | 1 |
| Chesselet, MF; Delfs, JM; Ellison, GD; Mercugliano, M | 1 |
| Fibiger, HC; Ikemoto, K; Maeda, T; Satoh, K | 1 |
| Jing, H; Lin, KW; Mei, MH | 1 |
| Larson, AA; Sun, X | 3 |
| Lau, SM; Tang, F | 1 |
| Hornfeldt, CS; Kitto, KF; Larson, AA | 1 |
| Bonastre, M; Chase, TN; Engber, TM; Marin, C; Tolosa, E | 1 |
| Bachus, SE; Egan, MF; Ferguson, J; Hamid, EH; Hurd, Y; Hyde, TM | 1 |
| Costa, AC; Mattioli, R; Santangelo, EM; Vasconcelos, L | 1 |
| Helke, CJ; Routh, VH | 1 |
| Augood, SJ; Emson, PC; Westmore, K | 1 |
| Cenarruzabeitia, E; Del Rio, J; Lasheras, B; Ramírez, MJ | 1 |
| Cheĭdo, MA | 1 |
| Mitsushio, H; Nishikawa, T; Shirayama, Y; Takahashi, K | 1 |
| Lindefors, N; Marcus, MM; Nomikos, GG; Svensson, TH; Zachrisson, O | 1 |
| Herlenius, E; Lindahl, SG; Takita, K; Yamamoto, Y | 1 |
| Nagai, C | 1 |
| Chen, L; Cui, QL; Xue, Y; Yung, WH | 1 |
| Cluderay, JE; Dada, A; Davies, CH; Dawson, LA; de la Flor, R; Hagan, JJ; Hill, MD; Jones, DN; Jones, GA; Langmead, CJ; Murkitt, GS; Smith, PW; Southam, E; Watson, JM; Wu, Z | 1 |
| Couture, R; De Brito Gariepy, H | 1 |
| Gentzel, RC; Hershey, J; Kandebo, M; Koser, AJ; Renger, JJ; Roberts, R; Smith, SM; Toolan, D; Uslaner, J | 1 |
2 review(s) available for haloperidol and substance p
| Article | Year |
|---|---|
Behavioral effects of substance P in rats.
Topics: Animals; Behavior, Animal; Dose-Response Relationship, Drug; Grooming; Haloperidol; Injections, Intraventricular; Motor Activity; Movement Disorders; Rats; Stereotyped Behavior; Substance P; Time Factors | 1980 |
[Progress in diagnosis of and therapy for diabetic choreic movement and ballismus].
Topics: Anti-Dyskinesia Agents; Basal Ganglia; Chorea; Diabetes Complications; Diabetes Mellitus; Dyskinesias; Enkephalins; gamma-Aminobutyric Acid; Haloperidol; Humans; Hypoglycemic Agents; Magnetic Resonance Imaging; Neurons; Substance P | 2004 |
72 other study(ies) available for haloperidol and substance p
| Article | Year |
|---|---|
Substance P content of substantia nigra after chronic treatment with antischizophrenic drugs.
Topics: Animals; Antipsychotic Agents; Clozapine; Haloperidol; Male; Pimozide; Rats; Substance P; Substantia Nigra; Time Factors | 1978 |
Evidence for a role of nigral gamma-aminobutyric acid and substance P in the haloperidol-induced activation of striatal tyrosine hydroxylase.
Topics: Aminobutyrates; Animals; Coenzymes; Corpus Striatum; Enzyme Activation; gamma-Aminobutyric Acid; Haloperidol; Male; Neural Pathways; Pteridines; Rats; Substance P; Substantia Nigra; Tyrosine 3-Monooxygenase | 1978 |
D-amphetamine administration reduces substance P concentration in the rat striatum.
Topics: Animals; Corpus Striatum; Depression, Chemical; Dextroamphetamine; Haloperidol; In Vitro Techniques; Male; Rats; Substance P; Time Factors | 1978 |
Eledoisin, substance P and related peptides: intracranial dipsogens in the pigeon and antidipsogens in the rat.
Topics: Angiotensin II; Animals; Atropine; Brain; Carbachol; Cerebral Ventricles; Columbidae; Corpus Striatum; Drinking; Eledoisin; Haloperidol; Hypothalamus; Phentolamine; Preoptic Area; Propranolol; Rats; Substance P | 1978 |
Participation of substance P in the action of haloperidol.
Topics: Animals; Brain Chemistry; Corpus Striatum; Haloperidol; Male; Rats; Substance P; Substantia Nigra | 1978 |
Tachykinin systems in the spinal cord and basal ganglia: influence of neonatal capsaicin treatment or dopaminergic intervention on levels of peptides, substance P-encoding mRNAs, and substance P receptor mRNA.
Topics: Animals; Animals, Newborn; Basal Ganglia; Blotting, Northern; Capsaicin; Chromatography, High Pressure Liquid; Dopamine Agents; Dynorphins; Endorphins; Female; Haloperidol; Injections, Subcutaneous; Neurokinin A; Neurons; Neurotoxins; Pregnancy; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Receptors, Neurotransmitter; RNA, Messenger; Spinal Cord; Substance P; Tachykinins | 1992 |
Effects of haloperidol and clozapine on preprotachykinin-A messenger RNA, tachykinin tissue levels, release and neurokinin-1 receptors in the striato-nigral system.
Topics: Animals; Binding, Competitive; Chromatography, High Pressure Liquid; Clozapine; Corpus Striatum; Dibenzazepines; Female; Haloperidol; Neural Pathways; Protein Precursors; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Neurokinin-2; Receptors, Neurotransmitter; RNA, Messenger; Substance P; Substantia Nigra; Tachykinins | 1990 |
Neuronal sites mediating locomotor hyperactivity following central neurokinin agonist administration.
Topics: Animals; Brain; Catheterization; Cerebral Ventricles; Chromatography, High Pressure Liquid; Haloperidol; Hydroxydopamines; Infusions, Parenteral; Male; Motor Activity; Muscimol; Neurons; Oxidopamine; Peptide Fragments; Pyrrolidonecarboxylic Acid; Rats; Rats, Inbred Strains; Substance P; Tegmentum Mesencephali | 1990 |
Substance P injections into the ventral tegmentum affect unit activity in mesolimbic terminal regions.
Topics: Animals; Electrophysiology; Haloperidol; Male; Microinjections; Neural Pathways; Nucleus Accumbens; Olfactory Bulb; Rats; Rats, Inbred Strains; Substance P; Tegmentum Mesencephali | 1991 |
Tachykinins in the rat substantia nigra: effects of selective dopamine receptor antagonists.
Topics: Amino Acid Sequence; Animals; Benzazepines; Chromatography, High Pressure Liquid; Dopamine Antagonists; Haloperidol; Male; Molecular Sequence Data; Neurokinin B; Radioimmunoassay; Rats; Rats, Inbred Strains; Substance P; Substantia Nigra; Sulpiride; Tachykinins | 1991 |
Behavioural and biochemical responses following activation of midbrain dopamine pathways by receptor selective neurokinin agonists.
Topics: Amino Acid Sequence; Animals; Chromatography, High Pressure Liquid; Dopamine; Haloperidol; Limbic System; Male; Mesencephalon; Molecular Sequence Data; Motor Activity; Neural Pathways; Neurokinin A; Peptide Fragments; Rats; Receptors, Neurotransmitter; Receptors, Tachykinin; Substance P; Substantia Nigra; Tegmentum Mesencephali | 1991 |
Rat anterior pituitary neuropeptides following chronic prolactin manipulation: a combined radioimmunoassay and mRNA study.
Topics: Animals; Blotting, Northern; Bromocriptine; Female; Galanin; Haloperidol; Hypothalamus; Neuropeptides; Peptides; Pituitary Gland, Anterior; Prolactin; Radioimmunoassay; Rats; Rats, Inbred Strains; RNA, Messenger; Substance P; Vasoactive Intestinal Peptide | 1991 |
Progabide reverses the nigral substance P reduction induced by chronic impairment of dopaminergic transmission.
Topics: Animals; gamma-Aminobutyric Acid; Haloperidol; Hydroxydopamines; Male; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, GABA-A; Substance P; Substantia Nigra; Synaptic Transmission; Tyrosine 3-Monooxygenase | 1985 |
Substance K, a novel tachykinin injected bilaterally into the ventral tegmental area of rats increases behavioral response.
Topics: Animals; Behavior, Animal; Dopamine; Dose-Response Relationship, Drug; Haloperidol; Male; Motor Activity; Nerve Tissue Proteins; Neurokinin A; Neurokinin B; Oligopeptides; Rats; Rats, Inbred Strains; Substance P; Tegmentum Mesencephali; Time Factors | 1985 |
Neuropeptide modulation of the behavioral effects of drugs.
Topics: Animals; Chlordiazepoxide; Columbidae; Conditioning, Psychological; Drug Interactions; Electroshock; Haloperidol; Neurotensin; Pentobarbital; Rabbits; Reinforcement, Psychology; Saimiri; Substance P; Thiazolidines; Thyrotropin-Releasing Hormone | 1985 |
Dopamine antagonist haloperidol decreases substance P, substance K, and preprotachykinin mRNAs in rat striatonigral neurons.
Topics: Animals; Corpus Striatum; Haloperidol; Kinetics; Male; Nerve Tissue Proteins; Neurokinin A; Neurons; Protein Precursors; Radioimmunoassay; Rats; Rats, Inbred Strains; RNA, Messenger; Substance P; Substantia Nigra; Tachykinins | 1986 |
Neuroleptic treatment induces region-specific changes in levels of neurokinin A and substance P in rat brain.
Topics: Animals; Brain; Cerebral Cortex; Chromatography, High Pressure Liquid; Corpus Striatum; Haloperidol; Male; Nerve Tissue Proteins; Neurokinin A; Nucleus Accumbens; Organ Specificity; Radioimmunoassay; Rats; Rats, Inbred Strains; Substance P; Substantia Nigra; Sulpiride | 1986 |
Chronic haloperidol and clozapine differentially affect dynorphin peptides and substance P in basal ganglia of the rat.
Topics: Animals; Basal Ganglia; Body Weight; Clozapine; Dibenzazepines; Dynorphins; Haloperidol; Injections, Intraperitoneal; Male; Protein Precursors; Radioimmunoassay; Rats; Rats, Inbred Strains; Substance P | 1986 |
Differential effects of acute and chronic administration of haloperidol on substance P and enkephalins in diverse rat brain areas.
Topics: Amygdala; Animals; Brain Chemistry; Corpus Striatum; Enkephalin, Leucine; Enkephalin, Methionine; Enkephalins; Haloperidol; Hypothalamus; Limbic System; Male; Pituitary Gland; Rats; Rats, Inbred Strains; Substance P; Substantia Nigra; Time Factors | 1986 |
Dopaminergic regulation of tachykinin metabolism in the striatonigral pathway.
Topics: Animals; Apomorphine; Brain Chemistry; Corpus Striatum; Dextroamphetamine; Dose-Response Relationship, Drug; Haloperidol; Male; Neurokinin A; Neuropeptides; Protein Precursors; Rats; Rats, Inbred F344; Receptors, Dopamine; RNA, Messenger; Substance P; Substantia Nigra; Tachykinins | 1987 |
Comparison between short- and long-term haloperidol administration on somatostatin and substance P concentrations in the rat brain.
Topics: Animals; Brain; Drug Administration Schedule; Haloperidol; Male; Organ Specificity; Rats; Rats, Inbred Strains; Somatostatin; Substance P; Time Factors | 1988 |
Effects of chronic treatment with trihexyphenidyl and carbamazepine alone or in combination with haloperidol on substance P content in rat brain: a possible implication of substance P in affective disorders.
Topics: Animals; Body Weight; Brain Chemistry; Carbamazepine; Dopamine; Dose-Response Relationship, Drug; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; Haloperidol; Lithium; Male; Mood Disorders; Rats; Rats, Inbred Strains; Serotonin; Substance P; Trihexyphenidyl | 1988 |
Quantitative radioimmunocytochemical evidence that haloperidol and SCH 23390 induce opposite changes in substance P levels of rat substantia nigra.
Topics: Animals; Autoradiography; Benzazepines; Biotin; Dose-Response Relationship, Drug; Haloperidol; Immunohistochemistry; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Substance P; Substantia Nigra | 1988 |
The NK-3 tachykinin agonist senktide elicits yawning and chewing mouth movements following subcutaneous administration in the rat. Evidence for cholinergic mediation.
Topics: Animals; Brain Chemistry; Dose-Response Relationship, Drug; Haloperidol; Hydroxydopamines; Injections, Subcutaneous; Male; Oxidopamine; Parasympathetic Nervous System; Peptide Fragments; Rats; Rats, Inbred Strains; Receptors, Neurotransmitter; Receptors, Tachykinin; Scopolamine; Stereotyped Behavior; Substance P; Yawning | 1988 |
Grooming behavior induced by substance P.
Topics: Animals; Dose-Response Relationship, Drug; Grooming; Haloperidol; Injections, Intraventricular; Male; Naloxone; Neurotensin; Rats; Rats, Inbred Strains; Substance P | 1988 |
Lithium increases rat striatal beta- and gamma-preprotachykinin messenger RNAs.
Topics: Animals; Corpus Striatum; Haloperidol; Immunohistochemistry; Lithium; Male; Neurokinin A; Protein Precursors; Rats; Rats, Inbred F344; RNA, Messenger; Substance P; Tachykinins | 1989 |
Neurokinin-alpha injected into the ventral tegmental area elicits a dopamine-dependent behavioral activation in the rat.
Topics: Animals; Behavior, Animal; Dopamine; Dose-Response Relationship, Drug; Haloperidol; Injections, Intraventricular; Male; Neurokinin A; Rats; Rats, Inbred Strains; Receptors, Dopamine; Substance P; Tegmentum Mesencephali | 1988 |
Subchronic haloperidol treatment decreases the in vivo release of tachykinins in rat substantia nigra.
Topics: Animals; Haloperidol; Male; Neurokinin A; Radioimmunoassay; Rats; Rats, Inbred Strains; Substance P; Substantia Nigra; Tachykinins; Time Factors | 1989 |
Effect of neurotensin, substance P and TRH on the regulation of dopamine receptors in rat brain.
Topics: Animals; Brain; Haloperidol; In Vitro Techniques; Male; Neurotensin; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiperone; Substance P; Thyrotropin-Releasing Hormone | 1984 |
D-Amphetamine reduces striatal substance P concentrations by presynaptic release of dopamine.
Topics: Animals; Corpus Striatum; Dextroamphetamine; Dopamine; Dose-Response Relationship, Drug; Haloperidol; Hypothalamus; Male; Methyltyrosines; Nerve Tissue Proteins; Organ Specificity; Rats; Substance P; Substantia Nigra | 1980 |
Effects of drugs infused into a rat hypophysial portal vessel on prolactin and growth hormone release.
Topics: Animals; Chlorpromazine; Dopamine Antagonists; Growth Hormone; Haloperidol; Levodopa; Male; Pituitary Gland; Prolactin; Rats; Substance P | 1980 |
Response of striatonigral substance P systems to a dopamine receptor agonist and antagonist.
Topics: Animals; Apomorphine; Corpus Striatum; Haloperidol; Male; Rats; Receptors, Dopamine; Substance P; Substantia Nigra | 1981 |
Influence of substance P on the behavioral changes induced by haloperidol in rats.
Topics: alpha-Methyltyrosine; Animals; Behavior, Animal; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Haloperidol; Locomotion; Methyltyrosines; Motor Activity; Phenoxybenzamine; Rats; Substance P; Tyrosine 3-Monooxygenase | 1980 |
Haloperidol-induced reduction of nigral substance P-like immunoreactivity: a probe for the interactions between dopamine and substance P neuronal systems.
Topics: Animals; Corpus Striatum; Dopamine; Dopamine Antagonists; Haloperidol; Male; Neurons; Rats; Substance P; Substantia Nigra | 1981 |
Substance P levels in the rat forebrain after apomorphine and haloperidol treatment.
Topics: Animals; Apomorphine; Brain; Haloperidol; Male; Rats; Receptors, Dopamine; Substance P | 1981 |
Effects of lithium and haloperidol administration on the rat brain levels of substance P.
Topics: Animals; Behavior, Animal; Brain Chemistry; Corpus Striatum; Enkephalin, Methionine; Haloperidol; Lithium; Male; Rats; Rats, Inbred F344; Substance P | 1983 |
Acute changes in nigral substance P content induced by drugs acting on dopamine, muscarine and GABA receptors.
Topics: Animals; Apomorphine; Haloperidol; Male; Oxotremorine; Picrotoxin; Rats; Receptors, Cell Surface; Receptors, Dopamine; Receptors, GABA-A; Receptors, Muscarinic; Substance P; Substantia Nigra | 1983 |
Cortical modulation of striatal function.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcholine; Animals; Cerebral Cortex; Choline O-Acetyltransferase; Corpus Striatum; Dopamine; Extrapyramidal Tracts; Frontal Lobe; Glutamate Decarboxylase; Haloperidol; Humans; Male; Motor Activity; Neural Pathways; Rats; Rats, Inbred Strains; Stereotyped Behavior; Substance P; Synaptic Transmission | 1982 |
Increases of substance P-like immunoreactivity within striatal-nigral structures after subacute methamphetamine treatment.
Topics: Animals; Corpus Striatum; Dextroamphetamine; Dopamine; Dose-Response Relationship, Drug; Haloperidol; Male; Methamphetamine; Rats; Serotonin; Substance P; Substantia Nigra | 1984 |
Changes in substance P concentrations after protein synthesis inhibition provide an index of substance P utilization.
Topics: Animals; Corpus Striatum; Cycloheximide; Dopamine; Haloperidol; Male; Nerve Tissue Proteins; Rats; Rats, Inbred Strains; Substance P; Substantia Nigra | 1984 |
Intranigral application of substance P antagonists prevents the haloperidol-induced activation of striatal tyrosine hydroxylase.
Topics: Animals; Bicuculline; Corpus Striatum; Dopamine; Enzyme Activation; Haloperidol; Kinetics; Male; Rats; Rats, Inbred Strains; Substance P; Substantia Nigra; Tyrosine 3-Monooxygenase | 1984 |
Control of tachykinin-evoked acetylcholine release from rat striatal slices by dopaminergic neurons.
Topics: Acetylcholine; Animals; Benzazepines; Clozapine; Dopamine; Dopamine Agents; Haloperidol; In Vitro Techniques; Male; Neostriatum; Neurons; Oxidopamine; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-3; Substance P; Tachykinins | 1993 |
Up-regulation of neurotensin mRNA in the rat striatum after acute methamphetamine treatment.
Topics: Animals; Autoradiography; Caffeine; Corpus Striatum; Gene Expression Regulation; Haloperidol; Male; Methamphetamine; Neurotensin; Olfactory Bulb; Oligonucleotide Probes; Rats; Rats, Sprague-Dawley; Reference Values; RNA, Messenger; Substance P; Sulfur Radioisotopes; Time Factors | 1994 |
Differential influence of haloperidol and sulpiride on dopamine receptors and peptide mRNA levels in the rat striatum and pituitary.
Topics: Animals; Blotting, Northern; Corpus Striatum; Enkephalins; Gene Expression Regulation; Growth Hormone; Haloperidol; In Situ Hybridization; Interleukin-6; Male; Neuropeptides; Pituitary Gland; Pituitary Hormones, Anterior; Pro-Opiomelanocortin; Prolactin; Protein Precursors; Rats; Receptors, Dopamine; Substance P; Sulpiride; Up-Regulation | 1994 |
Non-specific inhibition of dopamine receptor agonist-induced behaviour by the tachykinin NK1 receptor antagonist CP-99,994 in guinea-pigs.
Topics: Amphetamine; Analysis of Variance; Animals; Behavior, Animal; Dopamine Agonists; Grooming; Guinea Pigs; Haloperidol; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Motor Activity; Neurokinin A; Neurokinin-1 Receptor Antagonists; Oxazines; Piperidines; Receptors, Neurokinin-1; Stereoisomerism; Substance P | 1994 |
Pressor responses to electrical and chemical stimulation of the rat brain A10 dopaminergic system.
Topics: Animals; Benzazepines; Blood Pressure; Brain; Dopamine; Electric Stimulation; Haloperidol; Heart Rate; Male; Microinjections; Peptide Fragments; Pyrrolidonecarboxylic Acid; Rats; Rats, Sprague-Dawley; Stimulation, Chemical; Substance P; Ventral Tegmental Area | 1994 |
Alterations in mRNA levels of D2 receptors and neuropeptides in striatonigral and striatopallidal neurons of rats with neuroleptic-induced dyskinesias.
Topics: Animals; Basal Ganglia Diseases; Dynorphins; Dyskinesia, Drug-Induced; Enkephalins; Glutamate Decarboxylase; Haloperidol; In Situ Hybridization; Male; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; RNA, Messenger; Substance P | 1994 |
An osmium-free method of epon embedment that preserves both ultrastructure and antigenicity for post-embedding immunocytochemistry.
Topics: Animals; Antigens; Brain; Calcitonin Gene-Related Peptide; Epoxy Resins; gamma-Aminobutyric Acid; Glutamic Acid; Glutaral; Histological Techniques; Male; Microscopy, Immunoelectron; Neuropeptide Y; Neuropeptides; Neurotransmitter Agents; Osmium; Preservation, Biological; Rats; Rats, Sprague-Dawley; Substance P | 1995 |
GABAergic modulation of striatal peptide expression in rats and the alterations induced by dopamine antagonist treatment.
Topics: Animals; Baclofen; Benzazepines; Corpus Striatum; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Enkephalins; gamma-Aminobutyric Acid; Gene Expression Regulation; Glutamate Decarboxylase; Haloperidol; In Situ Hybridization; Male; Muscimol; Protein Precursors; Rats; Rats, Wistar; Receptors, GABA; RNA, Messenger; Salicylamides; Substance P; Tachykinins; Vigabatrin | 1994 |
Reinforcing properties of the neuropeptide substance P in Carassius auratus: evidence of dopaminergic system involvement.
Topics: Animals; Conditioning, Operant; Dopamine; Goldfish; Haloperidol; Reinforcement, Psychology; Substance P | 1995 |
Expression of glutamic acid decarboxylase mRNA in striatum and pallidum in an animal model of tardive dyskinesia.
Topics: Animals; Corpus Striatum; Dyskinesia, Drug-Induced; Enkephalins; Female; Gene Expression; Globus Pallidus; Glutamate Decarboxylase; Haloperidol; Rats; Rats, Sprague-Dawley; RNA, Messenger; Substance P | 1995 |
Neurochemical heterogeneity of the primate nucleus accumbens.
Topics: Animals; Basal Ganglia; Brain Mapping; Dopamine; Female; Haloperidol; Immunohistochemistry; Macaca; Male; Neuropeptides; Neurotensin; Nucleus Accumbens; Proto-Oncogene Proteins c-fos; Substance P | 1995 |
[Participation of dopamine on the muscarinergic inhibitory effect of substance P on gastric myoelectric activity and motility].
Topics: Animals; Caudate Nucleus; Dopamine; Dopamine Antagonists; Gastrointestinal Motility; Haloperidol; Male; Mice; Receptors, Dopamine D2; Receptors, Muscarinic; Substance P | 1995 |
The amino-terminus of substance P mimics and MK-801 attenuates the effects of capsaicin on nociception and kainic acid-induced behavior in the mouse.
Topics: Analysis of Variance; Animals; Capsaicin; Dizocilpine Maleate; Haloperidol; Kainic Acid; Male; Mice; Pain; Peptide Fragments; Piperazines; Receptors, N-Methyl-D-Aspartate; Substance P | 1993 |
MK-801 inhibits the effects of capsaicin in the adult mouse by an action involving phencyclidine (PCP) sites not linked to NMDA activity.
Topics: Animals; Behavior, Animal; Capsaicin; Dizocilpine Maleate; Haloperidol; Injections, Spinal; Kainic Acid; Male; Mice; Pain Measurement; Pain Threshold; Peptide Fragments; Piperazines; Receptors, N-Methyl-D-Aspartate; Receptors, Phencyclidine; Substance P | 1993 |
Regulation of sigma activity by the amino-terminus of substance P in the mouse spinal cord: involvement of phencyclidine (PCP) sites not linked to N-methyl-D-aspartate (NMDA) activity.
Topics: Animals; Behavior, Animal; Dizocilpine Maleate; Drug Synergism; Guanidines; Haloperidol; Injections, Spinal; Kainic Acid; Male; Mice; N-Methylaspartate; Peptide Fragments; Piperazines; Receptors, N-Methyl-D-Aspartate; Receptors, Phencyclidine; Receptors, sigma; Spinal Cord; Substance P; Up-Regulation | 1993 |
The effect of haloperidol on met-enkephalin, beta-endorphin, cholecystokinin and substance P in the pituitary, the hypothalamus and the striatum of rats during aging.
Topics: Aging; Animals; beta-Endorphin; Cholecystokinin; Corpus Striatum; Enkephalin, Methionine; Haloperidol; Hypothalamus; Male; Pituitary Gland; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Substance P | 1995 |
Evidence that the NH2-terminus of substance P modulates N-methyl-D-aspartate-induced activity by an action involving sigma receptors.
Topics: Analysis of Variance; Animals; Anticonvulsants; Antipsychotic Agents; Behavior, Animal; Drug Therapy, Combination; Excitatory Amino Acid Agonists; Guanidines; Haloperidol; Male; Mice; N-Methylaspartate; Receptors, sigma; Substance P | 1996 |
Effect of long-term haloperidol treatment on striatal neuropeptides: relation to stereotyped behavior.
Topics: Animals; Behavior, Animal; Dopamine Agonists; Dopamine Antagonists; Dynorphins; Enkephalins; Haloperidol; Male; Neostriatum; Neuropeptides; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Sensitivity and Specificity; Somatostatin; Stereotyped Behavior; Substance P; Time Factors | 1996 |
Pharmacological and neurochemical differences between acute and tardive vacuous chewing movements induced by haloperidol.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Corpus Striatum; Dynorphins; Dyskinesia, Drug-Induced; Enkephalins; Haloperidol; In Situ Hybridization; Male; Mastication; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; RNA, Messenger; Substance P | 1996 |
Substance P facilitates memory in goldfish in an appetitively motivated learning task.
Topics: Animals; Appetite; Discrimination Learning; Dopamine; Dopamine Antagonists; Goldfish; Haloperidol; Injections, Intraventricular; Learning; Memory; Reversal Learning; Substance P | 1997 |
A novel technique for producing antibody-coated microprobes using a thiol-terminal silane and a heterobifunctional crosslinker.
Topics: Animals; Antibodies; Autoradiography; Central Nervous System; Cross-Linking Reagents; Epoxy Resins; Glutaral; Microelectrodes; Rats; Silanes; Substance P; Sulfhydryl Compounds | 1997 |
Phenotypic characterization of neurotensin messenger RNA-expressing cells in the neuroleptic-treated rat striatum: a detailed cellular co-expression study.
Topics: Animals; Antipsychotic Agents; Dopamine and cAMP-Regulated Phosphoprotein 32; Enkephalins; Haloperidol; In Situ Hybridization; Male; Neostriatum; Nerve Tissue Proteins; Neurons; Neurotensin; Nucleus Accumbens; Oligonucleotides; Phenotype; Phosphoproteins; Rats; Rats, Wistar; RNA, Messenger; Substance P | 1997 |
5-HT2 receptor regulation of acetylcholine release induced by dopaminergic stimulation in rat striatal slices.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Acetylcholine; Animals; Benzazepines; Corpus Striatum; Dopamine Agonists; Dopamine Antagonists; Ergolines; Haloperidol; In Vitro Techniques; Ketanserin; Male; Neurokinin-1 Receptor Antagonists; Peptide Fragments; Physalaemin; Potassium; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Ritanserin; Serotonin Antagonists; Substance P | 1997 |
[The role of dopaminergic mechanism in the realization of immunostimulating effect of substance P and its analog].
Topics: Adjuvants, Immunologic; Animals; Antibody-Producing Cells; Dopamine; Dopamine Antagonists; Haloperidol; Hypothalamus; Male; Mice; Mice, Inbred CBA; Pituitary Gland; Rosette Formation; Substance P | 1997 |
Differential effects of haloperidol on phencyclidine-induced reduction in substance P contents in rat brain regions.
Topics: Animals; Brain; Corpus Striatum; Drug Interactions; Haloperidol; Limbic System; Male; Phencyclidine; Prefrontal Cortex; Prosencephalon; Rats; Rats, Wistar; Substance P; Substantia Nigra; Ventral Tegmental Area | 2000 |
Effects of antipsychotic drugs on cholecystokinin and preprotachykinin (substance P) mRNA expression in the rat hippocampal formation.
Topics: Animals; Antipsychotic Agents; Cholecystokinin; Clozapine; Gene Expression Regulation; Haloperidol; Hippocampus; Male; Neurons; Protein Precursors; Rats; Rats, Sprague-Dawley; RNA, Messenger; Substance P; Tachykinins; Transcription, Genetic | 2000 |
Effects of neuroactive substances on the morphine-induced respiratory depression; an in vitro study.
Topics: Acetylcholine; Animals; Animals, Newborn; Colforsin; Drug Interactions; Efferent Pathways; Haloperidol; Indomethacin; Morphine; Neurons; Neurotransmitter Agents; Quinacrine; Rats; Rats, Sprague-Dawley; Respiratory Center; Respiratory Insufficiency; Spinal Cord; Substance P; Thyrotropin-Releasing Hormone | 2000 |
Substance P excites globus pallidus neurons in vivo.
Topics: Action Potentials; Animals; Behavior, Animal; Choline O-Acetyltransferase; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Globus Pallidus; Haloperidol; Male; Neurokinin-1 Receptor Antagonists; Neurons; Neurotransmitter Agents; Posture; Rats; Rats, Wistar; Receptors, Neurokinin-1; Substance P; Tropanes | 2007 |
In vitro and in vivo comparison of two non-peptide tachykinin NK3 receptor antagonists: Improvements in efficacy achieved through enhanced brain penetration or altered pharmacological characteristics.
Topics: Aminoquinolines; Animals; Behavior, Animal; Brain; Cerebral Cortex; Cloning, Molecular; Dopamine; Extracellular Space; Guinea Pigs; Habenula; Haloperidol; Humans; Inositol Phosphates; Male; Microdialysis; Neurokinin B; Neurons; Nucleus Accumbens; Peptide Fragments; Peptides; Quinolines; Rats; Receptors, Tachykinin; Substance P | 2010 |
Blockade of tachykinin NK3 receptor reverses hypertension through a dopaminergic mechanism in the ventral tegmental area of spontaneously hypertensive rats.
Topics: Animals; Benzazepines; Blood Pressure; Dopamine; Haloperidol; Heart Rate; Hypertension; Ibotenic Acid; Indoles; Male; Oligopeptides; Peptide Fragments; Quinolines; Raclopride; Rats; Rats, Inbred SHR; Receptors, Neurokinin-3; Substance P; Ventral Tegmental Area | 2010 |
The PDE10A inhibitor MP-10 and haloperidol produce distinct gene expression profiles in the striatum and influence cataleptic behavior in rodents.
Topics: Animals; Catalepsy; Corpus Striatum; Cytoskeletal Proteins; Dopamine Antagonists; Dose-Response Relationship, Drug; Early Growth Response Protein 1; Enkephalins; Gene Expression; Gene Expression Profiling; Haloperidol; Male; Nerve Tissue Proteins; Neurons; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Proto-Oncogene Proteins c-fos; Pyrazoles; Quinolines; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Dopamine D2; Substance P; Substantia Nigra | 2015 |